Dementia  >>  galantamine hydrobromide  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
galantamine hydrobromide / Generic mfg.
NCT00416169: A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Completed
2
41
US
galantamine hydrobromide
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Frontotemporal Dementia, Pick Complex
 
07/04
MAyflOwer RoAD, NCT01677754 / 2012-000943-29: A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Completed
2
542
US, Canada, Europe, RoW
RO4602522, Placebo, Donepezil, Memantine, Rivastigmine, Galantamine
Hoffmann-La Roche
Alzheimer's Disease
06/15
06/15

Download Options